Mixed lineage kinase 3 (MLK3) has recently been shown to interact with cGKI as its substrate and to mediate the therapeutic effects of cGMP elevation on left ventricular pressure overload (transverse aortic constriction (TAC)) apparently via the nuclear factor transcription factor of activated T cells (NFAT). Here, MAP3K11 is linked to persistent truncus arteriosus.